Largest Shareholders Sign Deal to Prevent Lek's Takeover by Novartis?
Ljubljana, 9 October - After the Swiss drugs company Novartis published its takeover bid for Slovenian company Lek on 28 September, offering SIT 95,000 (EUR 415.68) per share, some 20 largest shareholders of Lek reconsidered their estimates of the company's value and decided to get more from the deal. As a radio report suggested, this group of Lek's shareholders has signed an agreement which could stop the takeover of the Ljubljana-based drugs company.
The rest of this news item is available to subscribers.
The news item consists of 636 characters (without spaces) or 126 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.